Riskpilot← Back to searchSign inGet full accessSFA Medical AB
ABActiveOrg 5592426737Erik Segersälls Väg 1Hospital activities · NACE 8610Est. 20200 employees
Revenue 2024
SEK 131K
+12% vs 2023
EBITDA margin
89.3%
+5% vs 2023
Equity ratio
85.3%
Financial strength
Net profit 2024
SEK 94K
+6% vs 2023
| Revenue | SEK 131K | +12% |
| EBITDA | SEK 117K | +5% |
| Net profit | SEK 94K | +6% |
| Total assets | SEK 210K | -33% |
| Equity | SEK 179K | -37% |
| Employees | 0 | — |
Legal name
SFA Medical AB
Org number
5592426737
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
17 februari 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna suppleanten
Company purpose
Föremål för bolagets verksamhet skall vara att, direkt eller indirekt, bedriva personaluthyrning inom vård och omsorg, konsultverksamhet inom verksamhetsutveckling, utbildning, IT och ekonomi, äga och förvalta fastigheter och värdepapper samt idka därmed förenlig verksamhet.
Address
Erik Segersälls Väg 1
Email
alessio.fz@tuta.io
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 82 | 143 | 178 | 118 | 131 |
| Staff expenses | — | — | −0 | — | — |
| EBITDA | 68 | 127 | 134 | 112 | 117 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 68 | 127 | 134 | 112 | 117 |
| Net financials | — | — | −0 | −0 | 1 |
| Profit before tax | 68 | 127 | 134 | 112 | 118 |
| Tax | −15 | −26 | −28 | −23 | −24 |
| Net profit | 53 | 101 | 107 | 89 | 94 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 84 | 221 | 241 | 314 | 210 |
| Equity | 78 | 180 | 196 | 285 | 179 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 6 | 41 | 44 | 29 | 31 |
| Total debt | 6 | 41 | 44 | 29 | 31 |
EBITDA margin
89.3%
This company
15.8%
Market median
+465% vs market
20202024
Equity ratio
85.3%
This company
38.2%
Market median
+123% vs market
20202024
Return on equity
52.6%
This company
18.4%
Market median
+186% vs market
20202024
Net profit margin
71.6%
This company
8.1%
Market median
+784% vs market
20202024
Asset turnover
0.63×
This company
1.12×
Market median
-44% vs market
20202024
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-02-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
| Chairman | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SFA Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Jonas Almqvist | Deputy Board Member | 0 companies |
| Hanna Maria Cecilia Falasca Zamponi | Board of Directors | 0 companies |
| Alessio Falasca Zamponi | Chairman | 0 companies |